Development of nucleic acid medicines based on chemical technology
Advanced Drug Delivery Reviews · 2023
DOI: 10.1016/j.addr.2023.114872 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023. Verfasst von Yusuke Kawamoto und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutics and Drug Metabolism, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo, Kyoto 606-8501, Japan. Elect…. Hauptthemen laut MEDLINE: Nucleic Acids, COVID-19. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 634 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biopharmaceutics and Drug Metabolism, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo, Kyoto 606-8501, Japan. Electronic address: y.kawamoto@pharm.kyoto-u.ac.jp.
- Department of Biopharmaceutics and Drug Metabolism, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo, Kyoto 606-8501, Japan.
- Department of Biopharmaceutics and Drug Metabolism, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo, Kyoto 606-8501, Japan. Electronic address: takakura@pharm.kyoto-u.ac.jp.
Zitieren
APA
Kawamoto, Y., Wu, Y., Takahashi, Y., & Takakura, Y. (2023). Development of nucleic acid medicines based on chemical technology. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2023.114872
Vancouver
Kawamoto Y, Wu Y, Takahashi Y, Takakura Y. Development of nucleic acid medicines based on chemical technology. Advanced Drug Delivery Reviews. 2023. doi:10.1016/j.addr.2023.114872
BibTeX
@article{Kawamoto2023,
author = {Kawamoto, Yusuke and Wu, You and Takahashi, Yuki and Takakura, Yoshinobu},
title = {Development of nucleic acid medicines based on chemical technology},
journal = {Advanced Drug Delivery Reviews},
year = {2023},
doi = {10.1016/j.addr.2023.114872}
}
EUVIMED